Notable Labs Operating Expenses 2013-2024 | NTBLQ

Notable Labs operating expenses from 2013 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
Notable Labs Annual Operating Expenses
(Millions of US $)
2023 $15
2022 $13
2021 $31
2020 $25
2019 $21
2018 $22
2017 $25
2016 $16
2015 $15
2014 $15
2013 $16
2012 $12
Notable Labs Quarterly Operating Expenses
(Millions of US $)
2024-06-30 $5
2024-03-31 $4
2023-12-31 $5
2023-09-30 $1
2023-06-30 $3
2023-03-31 $6
2022-12-31 $-17
2022-09-30 $10
2022-06-30 $10
2022-03-31 $11
2021-12-31 $9
2021-09-30 $7
2021-06-30 $8
2021-03-31 $7
2020-12-31 $7
2020-09-30 $6
2020-06-30 $6
2020-03-31 $6
2019-12-31 $6
2019-09-30 $5
2019-06-30 $5
2019-03-31 $5
2018-12-31 $4
2018-09-30 $6
2018-06-30 $4
2018-03-31 $7
2017-12-31 $8
2017-09-30 $6
2017-06-30 $5
2017-03-31 $5
2016-12-31 $5
2016-09-30 $3
2016-06-30 $3
2016-03-31 $5
2015-12-31 $3
2015-09-30 $6
2015-06-30 $3
2015-03-31 $3
2014-12-31 $5
2014-09-30 $3
2014-06-30 $3
2014-03-31 $3
2013-12-31
2013-09-30
2012-12-31
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.000B $0.000B
Notable Labs Ltd. is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Notable Labs Ltd., formerly known as Vascular Biogenics Ltd., is based in FOSTER CITY, Calif.
Stock Name Country Market Cap PE Ratio
Fanhua (AIFU) China $0.086B 2.07
Top KingWin (WAI) China $0.008B 0.00
S&W Seed (SANW) United States $0.006B 0.00
Invo BioScience (NAYA) United States $0.004B 0.00
Ocuphire Pharma (IRD) $0.000B 0.00